CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
New Haven, Connecticut, United States and 89 other locations
The purpose of this study is to evaluate the safety or treating pancreatic cancer with surgery to remove cancerour tissue, followed...
Phase 1
Commack, New York, United States and 6 other locations
The purpose of this study is to see how well the experimental imaging agent 89Zr-DFO-HuMab-5B1 attaches to pancreatic tumors, and to find ou....
Phase 1
Commack, New York, United States and 6 other locations
and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...
Phase 1
New Haven, Connecticut, United States and 17 other locations
treatment combinations in participants with metastatic Pancreatic Ductal Adenocarcinoma (PDAC).Two cohorts will be enrolled in parallel in t...
Phase 1, Phase 2
New Haven, Connecticut, United States and 26 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
New Haven, Connecticut, United States and 91 other locations
The purpose of this study is to confirm the recommended phase 2 dose (RP2D) of zolbetuximab in combination with Nab-P + GEM, determine overall surviv...
Phase 2
Meriden, Connecticut, United States and 137 other locations
treatment for people with locally advanced or borderline resectable pancreatic cancer. The researchers will also look at the safety...
Phase 1, Phase 2
Commack, New York, United States and 6 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumor...
Phase 2
New Haven, Connecticut, United States and 64 other locations
of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...
Phase 2
Commack, New York, United States and 48 other locations
Clinical trials
Research sites
Resources
Legal